ANDA 62953, held by Hikma. Clindamycin Phosphate.
As of Nov 15, 2026, ANDA 62953 (Clindamycin Phosphate), held by Hikma, was first approved by FDA on Apr 21, 1988, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 21, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clindamycin PhosphateEQ 150MG BASE/ML ยท injectable;injection | Clindamycin Phosphate | Discontinued |
| Dec 15, 1992 | Supplement 5Labeling | Approved | None posted |
| Oct 8, 1992 | Supplement 4Labeling | Approved | None posted |
| Jun 19, 1992 | Supplement 3Labeling | Approved | None posted |
| Nov 10, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Oct 17, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Apr 21, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters